Study Highlights Need for Additional Caregiver Support in Higher-Risk MDS
January 23rd 2024The study, which pulled self-reported data from online bulletin boards across the US, Canada, and the United Kingdom in 2020, found that the degree of burden varied based on patient disease stage, among other factors.
Read More
What We’re Reading: CAR T Therapy Warning; Child Flu Cases; Alzheimer Blood Test
January 23rd 2024Pharmaceutical companies required to update prescribing information for chimeric antigen receptor (CAR) T-cell therapies; Texas dashboard reports a 40% increase in pediatric flu cases; a blood test shows high accuracy for Alzheimer disease biomarkers.
Read More
Analysis Explores Gene Therapy’s Potential to Be Cost-Effective in SCD
January 22nd 2024This new economic valuation of the societal and health care benefits of gene therapy to treat sickle cell disease (SCD) concludes the highly personalized treatment has potential to be cost effective if priced below $2 million.
Read More
What We’re Reading: Global Pandemic Accord; New Abortion Initiatives; Cervical Cancer Increasing
January 22nd 2024Meeting the 2024 deadline for an international agreement on pandemic response may not happen; the Biden administration announces measures to counter restrictive state laws on abortion; cervical cancer incidence declines as more women receive the human papillomavirus vaccine.
Read More
Bolus Insulin Injection Frequency, Smart Pen Engagement Linked With Glycemic Control in T1D
January 22nd 2024A real-world study conducted across 9 European countries found that bolus injection frequency and engagement with a smart pen to administer insulin were associated with improved glycemic control among young adult patients with type 1 diabetes (T1D).
Read More
VR-Based Pulmonary Rehabilitation More Effective in Patients With COPD, Study Says
January 21st 2024Virtual reality (VR) combined with pulmonary rehabilitation was more effective than pulmonary rehabilitation alone in improving the pulmonary function, exercise capacity, and mental health of patients with chronic obstructive pulmonary disease (COPD).
Read More
Topical Corticosteroids: The Preferred First-Line Treatment for Pediatric Alopecia Areata
January 20th 2024A survey of pediatric dermatologists revealed that topical corticosteroids are the most common first-line treatment for children with alopecia areata, regardless of age or hair loss severity.
Read More
Study Highlights Treatment Patterns, Costs for DLBCL Not Treated With Stem Cell Transplant
January 19th 2024Most patients in the cohort received rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone for first-line therapy; hospitalization was prevalent; and average medical and pharmacy costs were more than $140,000 per patient per year.
Read More
The new Innovation in Behavioral Health (IBH) Model is designed to test for improving outcomes for adults with mental health and substance use disorder; patients with long COVID show prolonged activation of the immune system’s complement system after an acute infection; scientists now believe our bodies benefit most when our sleep is consistent, not just long.
Read More